Skip to content

Zimmer Biomet Holdings Inc Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Wed, Feb 10, 2027, before the market opens · estimates and history

Zimmer Biomet Holdings Inc · E.ZBH.NYSE · United States
Use symbol E.ZBH.NYSE in our API & Excel add-in to retrieve this data ↓
97.47
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 0%
Trend 50%
Bubble Risk LOW
Realised Volatility (20D) 28.09%

Zimmer Biomet Holdings Inc Forecast

Zimmer Biomet Holdings Inc short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is positive (6 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 28.1% a year, a typical one-standard-deviation range is 93.61–101.33 over a week, 89.57–105.37 over a month and 70.10–124.84 over a year. (Signals as of 1 Nov 2026.)

Zimmer Biomet Holdings Inc Price Chart

MacroFinance.ai

Zimmer Biomet Holdings Inc Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Zimmer Biomet Holdings Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Zimmer Biomet Holdings Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Zimmer Biomet Holdings Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Zimmer Biomet Holdings Inc
P/E
24.31x
Mid-range vs own history
QoQ +0.7%
YoY +6.8%
now 24.307221.1 low27.74 high
ⓘP/E As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Zimmer Biomet Holdings Inc
P/S
2.18x
Cheap vs own history
QoQ −4.9%
YoY −4.8%
now 2.17681.92 low2.42 high
ⓘP/S As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Zimmer Biomet Holdings Inc
P/B
1.47x
Mid-range vs own history
QoQ −4.9%
YoY +2.0%
now 1.4661.27 low1.59 high
ⓘP/B As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Zimmer Biomet Holdings Inc
EV/EBITDA
11.27x
Mid-range vs own history
QoQ −0.8%
YoY +6.6%
now 11.268610.01 low11.95 high
ⓘEV/EBITDA As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Zimmer Biomet Holdings Inc
EV/Sales
3.01x
Cheap vs own history
QoQ −3.6%
YoY −4.2%
now 3.00572.75 low3.27 high
ⓘEV/Sales As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Zimmer Biomet Holdings Inc
FCF Yield
7.3%
Strong vs own history
QoQ +11.0%
YoY −1.3%
now 7.25736.54 low7.82 high
ⓘFCF Yield As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Zimmer Biomet Holdings Inc
Earnings Yield
4.1%
Mid-range vs own history
QoQ −0.7%
YoY −6.4%
now 4.1143.6 low4.74 high
ⓘEarnings Yield As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Zimmer Biomet Holdings Inc
Dividend Yield
1.0%
Mid-range vs own history
QoQ +3.4%
YoY −3.9%
now 1.00080.92 low1.17 high
ⓘDividend Yield As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Zimmer Biomet Holdings Inc
Market Cap
$18.7B
Mid-range vs own history
QoQ −4.2%
YoY +1.8%
now 18655.75816,120 low20,210 high
ⓘMarket Cap As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Zimmer Biomet Holdings Inc
Net Debt
$7.1B
High vs own history
QoQ +0.5%
YoY +4.2%
now 7104.36,820 low7,104 high
ⓘNet Debt As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Zimmer Biomet Holdings Inc
Net Debt / EBITDA
3.11x
Mid-range vs own history
QoQ +2.7%
YoY +8.4%
now 3.10772.87 low3.12 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Zimmer Biomet Holdings Inc
Current Ratio
1.46x
Mid-range vs own history
QoQ −13.4%
YoY −39.7%
now 1.46441.46 low2.43 high
ⓘCurrent Ratio As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Zimmer Biomet Holdings Inc
Quick Ratio
0.79x
Mid-range vs own history
QoQ −15.9%
YoY −43.5%
now 0.78850.79 low1.39 high
ⓘQuick Ratio As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Zimmer Biomet Holdings Inc
Interest Coverage
4.09x
Mid-range vs own history
QoQ −3.9%
YoY −11.4%
now 4.08733.84 low4.61 high
ⓘInterest Coverage As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Zimmer Biomet Holdings Inc
Debt / Equity
0.59x
Mid-range vs own history
QoQ −0.5%
YoY −7.3%
now 0.58970.59 low0.64 high
ⓘDebt / Equity As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Zimmer Biomet Holdings Inc
Piotroski F-Score
6
Mid-range vs own history
QoQ 0.0%
YoY 0.0%
now 65 low6 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Zimmer Biomet Holdings Inc
Altman Z-Score
2.37
Weak vs own history
QoQ −6.9%
YoY −1.8%
now 2.36732.35 low2.54 high
ⓘAltman Z-Score As of 22 Nov 2026.See Zimmer Biomet Holdings Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Zimmer Biomet Holdings Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Zimmer Biomet Holdings Inc fundamentals: income statement, balance sheet & cash flow

Zimmer Biomet Holdings Inc reported revenue of $8.23bn and net income of $705.2m in FY2025, the year ended 31 December 2025 — revenue up 7.2% and net income down 22.0% on the prior year. Free cash flow was $1.47bn. These figures are as reported in the filings, not restated: 28 fiscal years and 107 quarters of history, back to December 1998. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$8.23bn
+7.2%
Net income
$705.2m
-22.0%
Gross margin
61.62%
Free cash flow
$1.47bn
+28.9%
Net debt
$6.93bn
Shares short (30 Oct 2026)
7.85m
3.89 days to cover
Zimmer Biomet Holdings Inc income statement, annual, as reported · USD millions unless stated
USD millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue8,231.57,678.67,394.26,939.96,827.3
Cost of revenue3,159.62,191.22,083.82,019.51,960.4
Gross profit5,071.95,487.45,310.44,920.44,866.9
Research & development458.5437.4458.7406.0435.8
Selling, general & admin.3,239.9————
Operating income1,362.21,285.71,277.7696.3860.3
EBITDA2,217.42,250.92,220.21,494.71,645.1
Interest expense292.8218.0201.2164.8208.4
Pre-tax income830.81,036.61,067.3403.5499.0
Income tax125.7131.442.2112.353.5
Net income705.2903.81,024.0231.4401.6

Download Zimmer Biomet Holdings Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.ZBH.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 28 fiscal years and 107 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Zimmer Biomet Holdings Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Zimmer Biomet Holdings Inc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Zimmer Biomet Holdings Inc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Zimmer Biomet Holdings Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Zimmer Biomet Holdings Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Zimmer Biomet Holdings Inc (United States)

Zimmer Biomet Holdings Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Zimmer Biomet Holdings Inc?
Zimmer Biomet Holdings Inc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Zimmer Biomet Holdings Inc price?
The latest close is 97.47 (1 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Zimmer Biomet Holdings Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is neutral (2 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is positive (6 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Zimmer Biomet Holdings Inc?
20-day realised volatility is 28.1% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 8.1% over a month and 4.0% over a week.
What factors affect Zimmer Biomet Holdings Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Zimmer Biomet Holdings Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Zimmer Biomet Holdings Inc?
58 backtested tactical asset allocation strategies trade Zimmer Biomet Holdings Inc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Zimmer Biomet Holdings Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of Zimmer Biomet Holdings Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Zimmer Biomet Holdings Inc historical data?
In the Free historical data section of this page: the last 10 years of Zimmer Biomet Holdings Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Zimmer Biomet Holdings Inc historical data (last 10 years)

Browse or instantly download the last 10 years of Zimmer Biomet Holdings Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.ZBH.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20101.1
2026-11-19101.47
2026-11-18103.32
2026-11-17102.09
2026-11-16101.41
2026-11-13103.21
2026-11-12104.56
2026-11-11107.47
2026-11-10107.32
2026-11-09108.33
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.